...
首页> 外文期刊>Inflammatory bowel diseases >Fibrosing colonopathy associated with treatment with enteric-coated mesalazine pills.
【24h】

Fibrosing colonopathy associated with treatment with enteric-coated mesalazine pills.

机译:与肠溶美沙拉嗪片治疗相关的纤维化结肠病变。

获取原文
获取原文并翻译 | 示例
           

摘要

Fibrosing colonopathy consists of the appearance of a thickening of the submucous layer of the colon due to proliferation of connective tissue together with a variable amount of fatty tissue. The dense fibrotic proliferation may cause stenosis of the lumen. This condition was first described by Smyth et al in 19941 in cystic fibrosis patients who were given high doses of pancreatic enzymes in the form of pills with an enteric coating of methacrylic acid (Eu-dragit).
机译:纤维化结肠病包括由于结缔组织的增生以及数量可变的脂肪组织而引起的结肠粘膜下层增厚的现象。密集的纤维化增生可能导致管腔狭窄。这种病首先由Smyth等人于19941年描述于囊性纤维化患者中,这些患者接受了高剂量的胰酶,其形式为带有甲基丙烯酸肠溶衣(Eu-dragit)的药丸形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号